News | June 23, 2025
Emcure to acquire remaining stake in Zuventus Healthcare
The transaction is expected to close in Q2 FY 2026
The transaction is expected to close in Q2 FY 2026
The company will provide the necessary response to USFDA within stipulated 15 days
Sun Pharma gets 8 observations from USFDA for Halol facility
Conceptulised by Lowe Lintas, the new campaign creatively brings the "fast action" benefit of Cipladine to life through a series of films
Zydus receives EIR for the API manufacturing facility at Ankleshwar
Globally, BRUKINSA is approved in more than 70 countries
Sun Pharma discontinues work on its experimental skin drug SCD-044 after Phase 2 trial results fall short of goals for treating psoriasis and atopic dermatitis
The approval is for the generic version of Victoza, indicated for the treatment of insufficiently controlled Type 2 Diabetes Mellitus
Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients
The company also announced results for the third quarter, reporting sales at Rs. 992 crore, flat versus year ago
Subscribe To Our Newsletter & Stay Updated
